Literature DB >> 15263088

Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model.

Luc Dupuis1, Hugues Oudart, Frédérique René, Jose-Luis Gonzalez de Aguilar, Jean-Philippe Loeffler.   

Abstract

Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease characterized by selective loss of motor neurons and progressive muscle wasting. Growing evidence indicates that mitochondrial dysfunction, not only occurring in motor neurons but also in skeletal muscle, may play a crucial role in the pathogenesis. In this regard, the life expectancy of the ALS G93A mouse line is extended by creatine, an intracellular energy shuttle that ameliorates muscle function. Moreover, a population of patients with sporadic ALS exhibits a generalized hypermetabolic state of as yet unknown origin. Altogether, these findings led us to explore whether alterations in energy homeostasis may contribute to the disease process. Here, we show important variations in a number of metabolic indicators in transgenic ALS mice, which in all shows a metabolic deficit. These alterations were accompanied early in the asymptomatic phase of the disease by reduced adipose tissue accumulation, increased energy expenditure, and concomitant skeletal muscle hypermetabolism. Compensating this energetic imbalance with a highly energetic diet extended mean survival by 20%. In conclusion, we suggest that hypermetabolism, mainly of muscular origin, may represent by itself an additional driven force involved in increasing motor neuron vulnerability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15263088      PMCID: PMC503756          DOI: 10.1073/pnas.0402026101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Towards a molecular understanding of adaptive thermogenesis.

Authors:  B B Lowell; B M Spiegelman
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

Review 2.  Obesity and the regulation of energy balance.

Authors:  B M Spiegelman; J S Flier
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

3.  Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death.

Authors:  G M Borthwick; M A Johnson; P G Ince; P J Shaw; D M Turnbull
Journal:  Ann Neurol       Date:  1999-11       Impact factor: 10.422

4.  SRC-1 and TIF2 control energy balance between white and brown adipose tissues.

Authors:  Frédéric Picard; Martine Géhin; Jean- Sébastien Annicotte; Stéphane Rocchi; Marie-France Champy; Bert W O'Malley; Pierre Chambon; Johan Auwerx
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

5.  A randomized sequential trial of creatine in amyotrophic lateral sclerosis.

Authors:  G J Groeneveld; Jan H Veldink; Ingeborg van der Tweel; Sandra Kalmijn; Cornelis Beijer; Marianne de Visser; John H J Wokke; Hessel Franssen; Leonard H van den Berg
Journal:  Ann Neurol       Date:  2003-04       Impact factor: 10.422

6.  Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis.

Authors:  S Vielhaber; D Kunz; K Winkler; F R Wiedemann; E Kirches; H Feistner; H J Heinze; C E Elger; W Schubert; W S Kunz
Journal:  Brain       Date:  2000-07       Impact factor: 13.501

7.  Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease.

Authors:  Maria Maddalena Lino; Corinna Schneider; Pico Caroni
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

8.  Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice.

Authors:  Marina Mattiazzi; Marilena D'Aurelio; Carl D Gajewski; Katherine Martushova; Mahmoud Kiaei; M Flint Beal; Giovanni Manfredi
Journal:  J Biol Chem       Date:  2002-06-05       Impact factor: 5.157

9.  Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis.

Authors:  Luc Dupuis; Jose-Luis Gonzalez de Aguilar; Franck di Scala; Frédérique Rene; Marc de Tapia; Pierre-François Pradat; Lucette Lacomblez; Danielle Seihlan; Rabinder Prinjha; Frank S Walsh; Vincent Meininger; Jean-Philippe Loeffler
Journal:  Neurobiol Dis       Date:  2002-08       Impact factor: 5.996

Review 10.  Nutritional issues and supplements in amyotrophic lateral sclerosis and other neurodegenerative disorders.

Authors:  Amy Cameron; Jeffrey Rosenfeld
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2002-11       Impact factor: 4.294

View more
  178 in total

Review 1.  Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Authors:  Richard S Bedlack; Nanette Joyce; Gregory T Carter; Sabrina Paganoni; Chafic Karam
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  The effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice.

Authors:  Matthew E R Butchbach; Jasbir Singh; Mark E Gurney; Arthur H M Burghes
Journal:  Exp Neurol       Date:  2014-03-25       Impact factor: 5.330

3.  SOD1-G93A mice exhibit muscle-fiber-type-specific decreases in glucose uptake in the absence of whole-body changes in metabolism.

Authors:  Susan E Smittkamp; Jill K Morris; Gregory L Bomhoff; Mark E Chertoff; Paige C Geiger; John A Stanford
Journal:  Neurodegener Dis       Date:  2013-09-06       Impact factor: 2.977

4.  Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials.

Authors:  Albert C Ludolph; Sarah Jesse
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

5.  Energy intake and amyotrophic lateral sclerosis.

Authors:  Mark P Mattson; Roy G Cutler; Simonetta Camandola
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

6.  The in vivo contribution of motor neuron TrkB receptors to mutant SOD1 motor neuron disease.

Authors:  Jinbin Zhai; Weiguo Zhou; Jian Li; Christopher R Hayworth; Lei Zhang; Hidemi Misawa; Rudiger Klein; Steven S Scherer; Rita J Balice-Gordon; Robert Gordon Kalb
Journal:  Hum Mol Genet       Date:  2011-08-04       Impact factor: 6.150

7.  Defective daily temperature regulation in a mouse model of amyotrophic lateral sclerosis.

Authors:  Maurine C Braun; Alexandra Castillo-Ruiz; Premananda Indic; Dae Young Jung; Jason K Kim; Robert H Brown; Steven J Swoap; William J Schwartz
Journal:  Exp Neurol       Date:  2018-07-18       Impact factor: 5.330

8.  Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial.

Authors:  Anne-Marie Wills; Jane Hubbard; Eric A Macklin; Jonathan Glass; Rup Tandan; Ericka P Simpson; Benjamin Brooks; Deborah Gelinas; Hiroshi Mitsumoto; Tahseen Mozaffar; Gregory P Hanes; Shafeeq S Ladha; Terry Heiman-Patterson; Jonathan Katz; Jau-Shin Lou; Katy Mahoney; Daniela Grasso; Robert Lawson; Hong Yu; Merit Cudkowicz
Journal:  Lancet       Date:  2014-02-28       Impact factor: 79.321

9.  Nanoformulated copper/zinc superoxide dismutase exerts differential effects on glucose vs lipid homeostasis depending on the diet composition possibly via altered AMPK signaling.

Authors:  Gopalakrishnan Natarajan; Curtis Perriotte-Olson; Fatema Bhinderwala; Robert Powers; Cyrus V Desouza; Geoffrey A Talmon; Jiang Yuhang; Matthew C Zimmerman; Alexander V Kabanov; Viswanathan Saraswathi
Journal:  Transl Res       Date:  2017-08-15       Impact factor: 7.012

10.  Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status.

Authors:  Christian Lunetta; Andrea Lizio; Lucio Tremolizzo; Massimiliano Ruscica; Chiara Macchi; Nilo Riva; Patrick Weydt; Ettore Corradi; Paolo Magni; Valeria Sansone
Journal:  J Neurol       Date:  2018-10-22       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.